- Title
- TLR2-mediated activation of innate responses in the upper airways confers antiviral protection of the lungs
- Creator
- Deliyannis, Georgia; Wong, Chinn Yi; McQuilten, Hayley A.; Bachem, Annabell; Clarke, Michele; Jia, Xiaoxiao; Horrocks, Kylie; Zeng, Weiguang; Girkin, Jason; Scott, Nichollas E.; Londrigan, Sarah L.; Reading, Patrick C.; Bartlett, Nathan W.; Kedzierska, Katherine; Brown, Lorena E.; Mercuri, Francesca; Demaison, Christophe; Jackson, David C.; Chua, Brendon Y.
- Relation
- NHMRC.1071916 http://purl.org/au-research/grants/nhmrc/1071916
- Relation
- JCI Insight Vol. 6, Issue 5, no. e140267
- Publisher Link
- http://dx.doi.org/10.1172/jci.insight.140267
- Publisher
- American Society for Clinical Investigation
- Resource Type
- journal article
- Date
- 2021
- Description
- The impact of respiratory virus infections on global health is felt not just during a pandemic, but endemic seasonal infections pose an equal and ongoing risk of severe disease. Moreover, vaccines and antiviral drugs are not always effective or available for many respiratory viruses. We investigated how induction of effective and appropriate antigen-independent innate immunity in the upper airways can prevent the spread of respiratory virus infection to the vulnerable lower airways. Activation of TLR2, when restricted to the nasal turbinates, resulted in prompt induction of innate immune-driven antiviral responses through action of cytokines, chemokines, and cellular activity in the upper but not the lower airways. We have defined how nasal epithelial cells and recruitment of macrophages work in concert and play pivotal roles to limit progression of influenza virus to the lungs and sustain protection for up to 7 days. These results reveal underlying mechanisms of how control of viral infection in the upper airways can occur and support the implementation of strategies that can activate TLR2 in nasal passages to provide rapid protection, especially for at-risk populations, against severe respiratory infection when vaccines and antiviral drugs are not always effective or available.
- Subject
- respiratory virus infections; global health; TLR2; influenza; SDG 3; Sustainable Development Goals
- Identifier
- http://hdl.handle.net/1959.13/1454609
- Identifier
- uon:44978
- Identifier
- ISSN:2379-3708
- Rights
- © 2021 Deliyannis et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
- Language
- eng
- Full Text
- Reviewed
- Hits: 8631
- Visitors: 8760
- Downloads: 144
Collections
Goal 3: Good Health and Well-Being
| Thumbnail | File | Description | Size | Format | |||
|---|---|---|---|---|---|---|---|
| View Details Download | ATTACHMENT02 | Publisher version (open access) | 1 MB | Adobe Acrobat PDF | View Details Download |